Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice (IRIS-ROTA)

December 22, 2023 updated by: Seung-Jung Park

Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice; A Multicenter, Prospective Observational Study

This study evaluates the effectiveness and safety rotational atherectomy in routine clinical practice.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bucheon, Korea, Republic of
        • Recruiting
        • Soon Chun Hyang University Hospital Bucheon
        • Contact:
          • Nae-Hee Lee, MD
        • Principal Investigator:
          • Nae-Hee Lee, MD
      • Daegu, Korea, Republic of
        • Recruiting
        • Daegu Catholic University Medical Center
        • Contact:
          • Kee-Sik Kim, MD
        • Principal Investigator:
          • Kee-Sik Kim, MD
      • Daejeon, Korea, Republic of
        • Terminated
        • Chungnam National University Hospital
      • Daejeon, Korea, Republic of
        • Withdrawn
        • The Catholic University of Korea, Daejeon St. Mary's Hospital
      • Gwangju, Korea, Republic of
        • Not yet recruiting
        • Chonnam National University Hospital
        • Contact:
          • Young-jun Hong, MD
        • Principal Investigator:
          • Young-jun Hong, MD
      • Pusan, Korea, Republic of
        • Active, not recruiting
        • Inje University Pusan Paik Hospital
      • Seongnam, Korea, Republic of
        • Terminated
        • Bundang CHA Hospital
      • Seoul, Korea, Republic of
        • Recruiting
        • Asan Medical Center
        • Contact:
          • Seung-jung Park, MD
        • Principal Investigator:
          • Seung-jung Park, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Consecutive percutaneous coronary intervention patients receiving rotational atherectomy

Description

Inclusion Criteria:

  • Patients ≥ 19 years old
  • Patients who received rotational atherectomy
  • The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion Criteria:

  • Life expectancy <1y

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Coronary disease
Percutaneous coronary intervention with rotational atherectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Target vessel failure (TVF)
Time Frame: 1 year
Target vessel failure (TVF) composite of death, nonfatal myocardial infarction (MI), or ischemic-driven Target Vessel Revascularization (TVR) at 12 months after the procedure.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All death
Time Frame: 1-,6-, and 12-months, and 3-,5-years
1-,6-, and 12-months, and 3-,5-years
Cardiac death
Time Frame: 1-,6-, and 12-months, and 3-,5-years
1-,6-, and 12-months, and 3-,5-years
Myocardial infarction
Time Frame: 1-,6-, and 12-months, and 3-,5-years
1-,6-, and 12-months, and 3-,5-years
Composite of death or myocardial infarction
Time Frame: 1-,6-, and 12-months, and 3-,5-years
1-,6-, and 12-months, and 3-,5-years
Composite of cardiac death or myocardial infarction
Time Frame: 1-,6-, and 12-months, and 3-,5-years
1-,6-, and 12-months, and 3-,5-years
Target-lesion revascularization (TLR)
Time Frame: 1-,6-, and 12-months, and 3-,5-years
1-,6-, and 12-months, and 3-,5-years
Target-vessel revascularization (TVR)
Time Frame: 1-,6-, and 12-months, and 3-,5-years
1-,6-, and 12-months, and 3-,5-years
Stent thrombosis
Time Frame: 1-,6-, and 12-months, and 3-,5-years
according to Academic Research Consortium (ARC) criteria
1-,6-, and 12-months, and 3-,5-years
Stroke
Time Frame: 1-,6-, and 12-months, and 3-,5-years
1-,6-, and 12-months, and 3-,5-years
Procedural success
Time Frame: 7 days
Post-procedural diameter stenosis < 30% without death, Q-wave myocardial infarction, or urgent revascularization during the index admission
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2018

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

February 5, 2018

First Submitted That Met QC Criteria

February 5, 2018

First Posted (Actual)

February 9, 2018

Study Record Updates

Last Update Posted (Actual)

December 26, 2023

Last Update Submitted That Met QC Criteria

December 22, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Stenosis

Clinical Trials on Rotational atherectomy

3
Subscribe